Cargando…

Multiple bacterial infections increase the risk of hepatic encephalopathy in patients with cirrhosis

OBJECTIVE: Patients with liver cirrhosis (LC) are at increased risk for bacterial infections. It is not fully understood how exposure to infections induces further development of hepatic encephalopathy (HE). This study estimated risks of infection associated with HE among patients with LC. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Lan-Ting, Chuah, Seng-Kee, Yang, Shih-Cheng, Liang, Chih-Ming, Wu, Cheng-Kun, Tai, Wei-Chen, Hung, Tsung-Hsing, Nguang, Seng-Howe, Wang, Jiunn-Wei, Tseng, Kuo-Lun, Ku, Ming-Kun, Hsu, Pin-I, Wu, Deng-Chyang, Hsu, Chien-Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945008/ https://www.ncbi.nlm.nih.gov/pubmed/29746564 http://dx.doi.org/10.1371/journal.pone.0197127

Ejemplares similares

Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan
por: Hung, Tsung-Hsing, et al.
Publicado: (2017)

The Association of Helicobacter pylori Eradication with the Occurrences of Chronic Kidney Diseases in Patients with Peptic Ulcer Diseases
por: Wang, Jiunn-Wei, et al.
Publicado: (2016)

Treatment and Cost of Hepatocellular Carcinoma: A Population-Based Cohort Study in Taiwan
por: Nguang, Seng-Howe, et al.
Publicado: (2018)

Risk of Rebleeding and Mortality in Cirrhotic Patients with Peptic Ulcer Bleeding: A 12-Year Nationwide Cohort Study
por: Yang, Shih-Cheng, et al.
Publicado: (2017)

The Role of Adjuvant Acid Suppression on the Outcomes of Bleeding Esophageal Varices after Endoscopic Variceal Ligation
por: Wu, Cheng-Kun, et al.
Publicado: (2017)

Risk factors influencing the outcome of peptic ulcer bleeding in chronic kidney disease after initial endoscopic hemostasis: A nationwide cohort study
por: Liang, Chih-Ming, et al.
Publicado: (2016)

Association between Helicobacter pylori eradication and the risk of coronary heart diseases
por: Wang, Jiunn-Wei, et al.
Publicado: (2018)

First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease
por: Liang, Chih-Ming, et al.
Publicado: (2017)

Predicting risk factors for rebleeding, infections, mortality following peptic ulcer bleeding in patients with cirrhosis and the impact of antibiotics prophylaxis at different clinical stages of the disease
por: Kuo, Ming-Te, et al.
Publicado: (2015)

The impact of aspirin on Klebsiella pneumoniae liver abscess in diabetic patients
por: Tai, Chien-Hsiang, et al.
Publicado: (2020)

A comparison between dexlansoprazole modified release–based and lansoprazole-based nonbismuth quadruple (concomitant) therapy for first-line Helicobacter pylori eradication: a prospective randomized trial
por: Tai, Wei-Chen, et al.
Publicado: (2019)

Increased Risk of Pyogenic Liver Abscess after Endoscopic Sphincterotomy for Treatment of Choledocholithiasis
por: Wu, Cheng-Kun, et al.
Publicado: (2021)

Clinical efficacy of 60-mg dexlansoprazole and 40-mg esomeprazole after 24 weeks for the on-demand treatment of gastroesophageal reflux disease grades A and B: a prospective randomized trial
por: Chiang, Hung-Hsien, et al.
Publicado: (2019)

Trend of changes in antibiotic resistance in Helicobacter pylori from 2013 to 2019: a multicentre report from Taiwan
por: Liang, Chih-Ming, et al.
Publicado: (2020)

The Role of Non-Selective β-Blockers in Compensated Cirrhotic Patients without Major Complications
por: Yeh, Wen-Shuo, et al.
Publicado: (2019)

Risk of Recurrent Peptic Ulcer Disease in Patients Receiving Cumulative Defined Daily Dose of Nonsteroidal Anti-Inflammatory Drugs
por: Liang, Chih-Ming, et al.
Publicado: (2019)

Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter pylori Treatment in Real World Clinical Practice
por: Hung, Kuo-Tung, et al.
Publicado: (2021)

Medical expenses in treating acute esophageal variceal bleeding: A 15-year nationwide population-based cohort study
por: Liu, Chueh-Ling, et al.
Publicado: (2016)

The Efficacy and Safety of 14-day Rabeprazole Plus Amoxicillin High Dose Dual Therapy by Comparing to 14-day Rabeprazole-Containing Hybrid Therapy for the Naïve Helicobacter pylori Infection in Taiwan: A Randomized Controlled Trial
por: Tai, Wei-Chen, et al.
Publicado: (2023)

First-line Helicobacter pylori eradication rates are significantly lower in patients with than those without type 2 diabetes mellitus
por: Yao, Chih-Chien, et al.
Publicado: (2019)

The Clinical Correlations of Helicobacter pylori Virulence Factors and Chronic Spontaneous Urticaria
por: Chiu, Yi-Chun, et al.
Publicado: (2013)

The Outcome of Prophylactic Intravenous Cefazolin and Ceftriaxone in Cirrhotic Patients at Different Clinical Stages of Disease after Endoscopic Interventions for Acute Variceal Hemorrhage
por: Wu, Cheng-Kun, et al.
Publicado: (2013)

Outcome of Holiday and Nonholiday Admission Patients with Acute Peptic Ulcer Bleeding: A Real-World Report from Southern Taiwan
por: Wu, Tsung-Chin, et al.
Publicado: (2014)

Quinolone-Containing Therapies in the Eradication of Helicobacter pylori
por: Chuah, Seng-Kee, et al.
Publicado: (2014)

Update on the second-line treatment of Helicobacter pylori infection: a narrative review
por: Shih, Chih-An, et al.
Publicado: (2023)

The efficacies of non-bismuth containing quadruple therapies in the treatment of first-line anti-Helicobacter pylori across 4-year time interval with changing antibiotics resistance
por: Huang, Tzu-Hsin, et al.
Publicado: (2021)

The Clinical Presentations of Liver Abscess Development After Endoscopic Retrograde Cholangiopancreatography with Choledocholithiasis: A 17-Year Follow-Up
por: Liu, An-Che, et al.
Publicado: (2023)

Efficacy of a 14-day quadruple-therapy regimen for third-line Helicobacter pylori eradication
por: Huang, Hsiang Tso, et al.
Publicado: (2018)

Endoscopic Management of Foreign Bodies in the Upper Gastrointestinal Tract of Adults
por: Yao, Chih-Chien, et al.
Publicado: (2015)

A Prognostic Model Using Inflammation- and Nutrition-Based Scores in Patients With Metastatic Gastric Adenocarcinoma Treated With Chemotherapy
por: Hsieh, Meng-Che, et al.
Publicado: (2016)

The Influential Roles of Antibiotics Prophylaxis in Cirrhotic Patients with Peptic Ulcer Bleeding after Initial Endoscopic Treatments
por: Yang, Shih-Cheng, et al.
Publicado: (2014)

The Effects of Ginger on Gallbladder Motility in Healthy Male Humans
por: Chuah, Seng-Kee, et al.
Publicado: (2011)

Peptic Ulcer Diseases: Genetics, Mechanism, and Therapies
por: Chuah, Seng-Kee, et al.
Publicado: (2014)

The efficacy of limited endoscopic sphincterotomy plus endoscopic papillary large balloon dilation for removal of large bile duct stones
por: Kuo, Chung-Mou, et al.
Publicado: (2019)

Acid suppressive agents and risk of Mycobacterium Tuberculosis: case–control study
por: Hsu, Wen-Hung, et al.
Publicado: (2014)

Comparison of the Efficacies of Direct-Acting Antiviral Treatment for HCV Infection in People Who Inject Drugs and Non-Drug Users
por: Hsu, Jui-Ting, et al.
Publicado: (2022)

Factors Associated with Colorectal Polyps in Middle-Aged and Elderly Populations
por: Loke, Song-Seng, et al.
Publicado: (2022)

The effects of hospice-shared care for gastric cancer patients
por: Huang, Kun-Siang, et al.
Publicado: (2017)

Limited precut sphincterotomy combined with endoscopic papillary balloon dilation for common bile duct stone removal in patients with difficult biliary cannulation
por: Kuo, Chung-Mou, et al.
Publicado: (2016)

Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis
por: Liang, Chih-Ming, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jo9jnmiapf2v6hrv0es2dmvosm